Severity
Moderate
FDA Drug recall · Reported October 23, 2013
Presence of Foreign Substance: process-related particulates which may be associated with the raw materials were observed
Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc. recalled Concentrated Motrin (ibuprofen) Infants' Drops Oral Suspension, Original Berry Flavor 1/2… - a moderate-severity action.
Concentrated Motrin (ibuprofen) Infants' Drops Oral Suspension, Original Berry Flavor 1/2… was recalled by Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc. in October 23, 2013. Reason: Presence of Foreign Substance: process-related particulates which may be associated with the raw materials we…. Check the official notice for the remedy. Verify recall #D-66272-001 with the FDA Drug before acting.
The recall
Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc. issued this moderate-severity FDA Drug recall-Presence of Foreign Substance: process-related particulates which may be associated with the raw materials we….
Sourced from official FDA Drug enforcement records. Verify recall #D-66272-001 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-66272-001) was formally reported on October 23, 2013, with the manufacturer initiating the action on September 6, 2013. It is classified under Moderate severity (Class II), with a current status of Terminated. Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc. is listed as the recalling firm, operating out of Fort Washington, PA. Federal records list the affected scope as 197,532 bottles.
The documented reason for this recall is: Presence of Foreign Substance: process-related particulates which may be associated with the raw materials were observed Distribution data in the federal record shows the product reached: Nationwide.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
197,532 bottles
Related Recalls
6
5 from same agency
Concentrated Motrin (ibuprofen) Infants' Drops Oral Suspension, Original Berry Flavor 1/2 fl oz bottles, 50 mg per 1.25ml, Distributed by McNeil Consumer Healthcare, Fort Washington, PA.
Presence of Foreign Substance: process-related particulates which may be associated with the raw materials were observed
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-66272-001 |
| Date reported | October 23, 2013 |
| Date initiated | September 6, 2013 |
| Recalling firm | Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc. |
| Firm location | Fort Washington, PA |
| Affected scope | 197,532 bottles |
| Distribution | Nationwide. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported October 23, 2013. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.